Gene · 2532
Papers3,550
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,550
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel Approaches to Possible Targeted Therapies and Prophylaxis of Uterine Fibroids. | Diseases | 2023 | 37987267 | PubTator, text mining | PubMed |
| Stemness signature and targeted therapeutic drugs identification for Triple Negative Breast Cancer. | Sci Data | 2023 | 37985782 | PubTator, text mining | PubMed |
| Plasmodium vivax merozoite-specific thrombospondin-related anonymous protein (PvMTRAP) interacts with human CD36, suggesting a novel ligand-receptor interaction for reticulocyte invasion. | Parasit Vectors | 2023 | 37981686 | PubTator, text mining | PubMed |
| Bovine papular stomatitis virus as a vaccine vector for cattle. | J Gen Virol | 2023 | 37976092 | PubTator, text mining | PubMed |
| Secondary metabolites of Bacillus subtilis L2 show antiviral activity against pseudorabies virus. | Front Microbiol | 2023 | 37965547 | PubTator, text mining | PubMed |
| Chemokines, molecular drivers of thromboinflammation and immunothrombosis. | Front Immunol | 2023 | 37954596 | PubTator, text mining | PubMed |
| Breast Cancer Germline Genetic Counseling and Testing for Populations of African Heritage Globally: A Scoping Review on Research, Practice, and Bioethical Considerations. | JCO Glob Oncol | 2023 | 37944088 | PubTator, text mining | PubMed |
| Mutant RB1 enhances therapeutic efficacy of PARPis in lung adenocarcinoma by triggering the cGAS/STING pathway. | JCI Insight | 2023 | 37937640 | PubTator, text mining | PubMed |
| Engineered CHO cells as a novel AAV production platform for gene therapy delivery. | Sci Rep | 2023 | 37932360 | PubTator, text mining | PubMed |
| Invisible Infrastructure in Haematology: Neutrophil Reference Ranges and the Duffy-null Phenotype. | Hemasphere | 2023 | 37908860 | PubTator, text mining | PubMed |
| From Physiology to Pathology: The Role of Mitochondria in Acute Kidney Injuries and Chronic Kidney Diseases. | Kidney Dis (Basel) | 2023 | 37901706 | PubTator, text mining | PubMed |
| The Role of the Duffy Blood Group Antigens in Renal Transplantation and Rejection. A Mini Review. | Transpl Int | 2023 | 37901300 | PubTator, text mining | PubMed |
| Prostate Cancer Microvascular Routes: Exploration and Measurement Strategies. | Life (Basel) | 2023 | 37895416 | PubTator, text mining | PubMed |
| Enhanced Anti-Herpetic Activity of Valacyclovir Loaded in Sulfobutyl-ether-β-cyclodextrin-decorated Chitosan Nanodroplets. | Microorganisms | 2023 | 37894118 | PubTator, text mining | PubMed |
| Small Molecule Targeting Immune Cells: A Novel Approach for Cancer Treatment. | Biomedicines | 2023 | 37892995 | PubTator, text mining | PubMed |
| Plasmodium knowlesi (Pk) Malaria: A Review & Proposal of Therapeutically Rational Exchange (T-REX) of Pk-Resistant Red Blood Cells. | Trop Med Infect Dis | 2023 | 37888606 | PubTator, text mining | PubMed |
| White Adipose Tissue Heterogeneity in the Single-Cell Era: From Mice and Humans to Cattle. | Biology (Basel) | 2023 | 37886999 | PubTator, text mining | PubMed |
| The chicken chorioallantoic membrane model for isolation of CRISPR/cas9-based HSV-1 mutant expressing tumor suppressor p53. | PLoS One | 2023 | 37862369 | PubTator, text mining | PubMed |
| The mutations on the envelope glycoprotein D contribute to the enhanced neurotropism of the pseudorabies virus variant. | J Biol Chem | 2023 | 37838171 | PubTator, text mining | PubMed |
| Plant Cell-Engineered Gold Nanoparticles Conjugated to Quercetin Inhibit SARS-CoV-2 and HSV-1 Entry. | Int J Mol Sci | 2023 | 37834240 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2532/papers?page=14